Unnamed: 0,title,date,stock,sentiment
271199.0,"Stifel Maintains Buy on Conmed, Raises Price Target to $82",2020-04-30 08:51:00-04:00,CNMD,neutral
271200.0,"Conmed Q1 EPS $0.510 Misses $0.540 Estimate, Sales $214.000M Miss $221.710M Estimate",2020-04-29 16:16:00-04:00,CNMD,negative
271201.0,"JP Morgan Maintains Overweight on Conmed, Lowers Price Target to $76",2020-04-23 09:26:00-04:00,CNMD,negative
271202.0,Shares of several healthcare companies are trading lower amid market volatility. Sunday's fiscal stimulus bill failed a procedural senate vote while the Fed Monday morning announced further stimulus measures to support liquidity.,2020-03-23 11:31:00-04:00,CNMD,negative
271203.0,"CONMED 8-K Shows Withdrawing Q1, FY20 Guidance",2020-03-20 06:10:00-04:00,CNMD,neutral
271204.0,Stocks That Hit 52-Week Lows On Thursday,2020-03-12 12:10:00-04:00,CNMD,negative
271205.0,"CONMED Sees ORganic Constant Currency Revenue Growth For Q1 To Be In 2%-4% Range, Compared To Previous Range Of 5%-6% As A Result Of coronavirus Impact",2020-03-10 07:01:00-04:00,CNMD,positive
271206.0,"Benzinga's Top Upgrades, Downgrades For November 26, 2019",2019-11-26 09:59:00-05:00,CNMD,positive
271207.0,Needham Downgrades Conmed to Hold,2019-11-26 07:07:00-05:00,CNMD,neutral
271208.0,Stocks That Hit 52-Week Highs On Monday,2019-11-25 10:19:00-05:00,CNMD,neutral
271209.0,Stocks That Hit 52-Week Highs On Wednesday,2019-11-20 10:12:00-05:00,CNMD,neutral
271210.0,Stocks That Hit 52-Week Highs On Monday,2019-11-18 11:01:00-05:00,CNMD,neutral
271211.0,"Benzinga's Top Upgrades, Downgrades For November 12, 2019",2019-11-12 09:37:00-05:00,CNMD,positive
271212.0,"JP Morgan Initiates Coverage On Conmed with Overweight Rating, Announces $136 Price Target",2019-11-12 06:22:00-05:00,CNMD,neutral
271213.0,Stocks That Hit 52-Week Highs On Monday,2019-11-04 14:43:00-05:00,CNMD,neutral
271214.0,"Stifel Nicolaus Maintains Buy on Conmed, Raises Price Target to $118",2019-10-31 08:51:00-04:00,CNMD,neutral
271215.0,Conmed Sees FY19 Sales Guidance $951M-$957M vs $954.85M Est.,2019-10-30 16:20:00-04:00,CNMD,neutral
271216.0,Conmed Raises FY19 EPS Guidance From $2.52-$2.57 To $2.62-$2.65 vs $2.54 Est.,2019-10-30 16:19:00-04:00,CNMD,neutral
271217.0,"Conmed Q3 EPS $0.62 Beats $0.56 Estimate, Sales $233.6M Beat $227.93M Estimate",2019-10-30 16:15:00-04:00,CNMD,neutral
271218.0,"The Daily Biotech Pulse: NewLink Genetics Rallies, Breakthrough Designation For Roche, IGM Biosciences Debuts",2019-09-18 07:39:00-04:00,CNMD,neutral
271219.0,Stocks That Hit 52-Week Highs On Tuesday,2019-09-17 10:40:00-04:00,CNMD,neutral
271220.0,Stocks That Hit 52-Week Highs On Thursday,2019-08-22 10:32:00-04:00,CNMD,neutral
271221.0,"Benzinga's Top Upgrades, Downgrades For August 22, 2019",2019-08-22 09:35:00-04:00,CNMD,positive
271222.0,10 Biggest Price Target Changes For Thursday,2019-08-22 09:05:00-04:00,CNMD,neutral
271223.0,"Piper Jaffray Upgrades Conmed to Overweight, Raises Price Target to $110",2019-08-22 06:26:00-04:00,CNMD,negative
271224.0,Stocks That Hit 52-Week Highs On Tuesday,2019-08-20 10:27:00-04:00,CNMD,neutral
271225.0,Stocks That Hit 52-Week Highs Of Monday,2019-08-12 10:31:00-04:00,CNMD,neutral
271226.0,Stocks That Set New 52-Week Highs Thursday,2019-08-08 12:19:00-04:00,CNMD,neutral
271227.0,Stocks That Broke Yearly Highs Thursday Morning,2019-08-01 10:19:00-04:00,CNMD,negative
271228.0,Stocks That Managed to Breach 52-Week Highs Wednesday Morning,2019-07-31 11:01:00-04:00,CNMD,neutral
271229.0,"The Daily Biotech Pulse: Neurocrine's Parkinson's Drug Accepted For Review, Sunesis Offering, No Headaches For Biohaven's Migraine Drug",2019-07-11 06:17:00-04:00,CNMD,neutral
271230.0,"The Daily Biotech Pulse: DiaMedica Reports Positive Data For Chronic Kidney Disease Drug, Eloxx Offering, IPO Deluge",2019-06-20 07:25:00-04:00,CNMD,positive
271231.0,"Conmed Q1 Adj. EPS $0.57 Beats $0.54 Estimate, Sales $218.378M Beat $210.62M Estimate",2019-04-24 16:02:00-04:00,CNMD,neutral
271232.0,"Shares of several healthcare stocks are trading higher in a potential rebound from last week's selloff. In an upgrade of HCA Healthcare, Raymond James analysts noted the selloff was 'based on legislation that has almost no chance of passing'",2019-04-23 11:52:00-04:00,CNMD,positive
271233.0,"Benzinga's Top Upgrades, Downgrades For April 18, 2019",2019-04-18 09:52:00-04:00,CNMD,positive
271234.0,"Stifel Nicolaus Initiates Coverage On Conmed with Buy Rating, Announces $95 Price Target",2019-04-18 07:32:00-04:00,CNMD,neutral
271235.0,Shares of several medical device companies are trading lower with the healthcare sector. Healthcare has seen weakness recently due to concerns over the future of the Affordable Act under Trump and healthcare policy uncertainty ahead of the 2020 election.,2019-04-17 12:45:00-04:00,CNMD,negative
271236.0,"Barclays Maintains Overweight on Conmed, Raises Price Target to $92",2019-04-15 09:54:00-04:00,CNMD,negative
271237.0,"Barclays Reinstates Overweight on Conmed, Announces $85",2019-02-19 07:26:00-05:00,CNMD,negative
271238.0,Conmed shares are trading higher the company beat Q4 EPS and sales estimates.,2019-01-23 10:47:00-05:00,CNMD,positive
271239.0,CONMED Corporation Sees FY19 Adj. EPS $2.42-$2.47 vs $2.42 Est.,2019-01-22 16:06:00-05:00,CNMD,neutral
271240.0,"Conmed Q4 Adj. EPS $0.73 Beats $0.72 Estimate, Sales $242.4M Beat $228.8M Estimate",2019-01-22 16:05:00-05:00,CNMD,neutral
271241.0,"Earnings Scheduled For January 22, 2019",2019-01-22 04:01:00-05:00,CNMD,neutral
271242.0,Shares of Conmed are trading down 5.2% after the company announced a definitive agreement to acquire Buffalo Filter for $365 million.,2018-12-14 13:46:00-05:00,CNMD,positive
271243.0,CONMED Announces Definitive Agreement To Acquire Buffalo Filter LLC For $365M,2018-12-13 16:01:00-05:00,CNMD,positive
271244.0,"Stocks That Will Be Trading Ex Dividend Thurs., Dec. 13, 2018",2018-12-12 11:15:00-05:00,CNMD,neutral
271245.0,Conmed Maintains FY2018 EPS Guidance of $2.15-2.20 vs $2.17 Est,2018-11-01 16:29:00-04:00,CNMD,neutral
271246.0,"CONMED Corporation Q3 EPS $0.46, Inline, Sales $202.3M Beat $198.46M Estimate",2018-11-01 16:27:00-04:00,CNMD,neutral
271247.0,"Barclays Initiates Coverage On Conmed with Equal-Weight Rating, Announces $78 Price Target",2018-10-16 07:10:00-04:00,CNMD,neutral
271248.0,"Stocks Trading Ex Dividend For Thurs., Sep. 13, 2018",2018-09-14 07:09:00-04:00,CNMD,neutral
271249.0,"Stocks Trading Ex Dividend For Thurs., Sep. 13, 2018",2018-09-13 09:42:00-04:00,CNMD,neutral
271250.0,"Stocks Which Set New 52-Week High Yesterday, August 2nd",2018-08-03 11:16:00-04:00,CNMD,neutral
271251.0,"Stocks Which Set New 52-Week High Yesterday, August 1st",2018-08-02 10:56:00-04:00,CNMD,neutral
271252.0,Conmed Sees FY18 Adj. EPS $$2.15-$2.20 vs $2.17 Est.,2018-08-01 16:12:00-04:00,CNMD,neutral
271253.0,"Conmed Q2 Adj. EPS $0.46 Beats $0.45 Estimate, Sales $212.8M Beat $207.12M Estimate",2018-08-01 16:12:00-04:00,CNMD,neutral
271254.0,"Benzinga's Daily Biotech Pulse: AbbVie Launches New Pediatric Humira, IPO Deluge Hits The Street",2018-06-21 08:39:00-04:00,CNMD,neutral
271255.0,"Benzinga's Daily Biotech Pulse: Hematology Conference In The Spotlight, Dr. Reddy To Launch Generic Opioid Addiction Drug",2018-06-15 09:13:00-04:00,CNMD,neutral
271256.0,"Benzinga's Daily Biotech Pulse: Johnson & Johnson to Dispose Sterilization Products Business, Mixed Results From Protesostasis' Cystic Fibrosis Study",2018-06-07 07:58:00-04:00,CNMD,neutral
271257.0,"Benzinga's Daily Biotech Pulse: Vascular Biogenics Soars On Positive Platform Data, Axovant Licenses Parkinson's Candidate",2018-06-06 08:38:00-04:00,CNMD,positive
271258.0,"Benzinga's Daily Biotech Pulse: Mylan's Neulasta Biosimilar Approved, Portola's CEO To Retire, Regenxbio To Join S&P SmallCap Index",2018-06-05 08:05:00-04:00,CNMD,positive
271259.0,"Benzinga's Daily Biotech Pulse: Transenterix Rises, Mylan Earnings, Deutsche Bank Conference Underway",2018-05-09 07:48:00-04:00,CNMD,neutral
271260.0,CONMED Raises FY18 Adj EPS Guidance From $2.11-$2.17 to $2.15-$2.20 vs $2.14 Est.,2018-04-25 16:42:00-04:00,CNMD,neutral
271261.0,"CONMED Q1 Adj. EPS $0.53 Beats $0.44 Est., Sales $202.1M Beats $196.4M Est.",2018-04-25 16:41:00-04:00,CNMD,neutral
271262.0,CONMED Names Todd Garner CFO,2018-01-02 16:02:00-05:00,CNMD,neutral
271263.0,CONMED CFO Luke Pomilio To Retire,2017-11-02 16:37:00-04:00,CNMD,neutral
271264.0,CONMED Narrows FY17 Adj. EPS Outlook From $1.85-$1.95 To $1.85-$1.90 vs $1.87 Est.,2017-11-02 16:01:00-04:00,CNMD,neutral
271265.0,"CONMED Reports Q3 Adj. EPS $0.42 vs $0.41 Est., Sales $190.1M vs $187M Est.",2017-11-02 16:01:00-04:00,CNMD,neutral
271268.0,Ladenburg Thalmann Downgrades Conmed to Neutral,2017-04-27 08:54:00-04:00,CNMD,neutral
271269.0,"CONMED Reports Q1 Adj. $0.38 vs $0.35 Est., Sales $186.6M vs $181.38M Est.",2017-04-26 16:24:00-04:00,CNMD,neutral
271270.0,"CONMED Subsidiary SurgiQuest Found Liable For False Advertising, Jury Awards $10M In Punitive Damages Against The Co.",2017-04-13 12:05:00-04:00,CNMD,negative
271271.0,CONMED Sees No Change To Previously Issued Guidance,2016-10-27 16:47:00-04:00,CNMD,negative
271272.0,"CONMED Corp. Reports Q3 EPS $0.41 vs. Est. $0.40, Rev. $184.8M vs. Est. $180M",2016-10-27 16:47:00-04:00,CNMD,neutral
271273.0,Leerink Swann Downgrades Conmed to Market Perform,2016-07-28 07:49:00-04:00,CNMD,neutral
271274.0,CONMED Cuts FY16 Sales $768M-$778M to $757M-$767M vs $771M Est.,2016-07-27 17:25:00-04:00,CNMD,negative
271275.0,"CONMED Reports Q2 Adj. EPS $0.47 vs $0.46 Est., Sales $193.4M vs $191.5M Est.",2016-07-27 17:24:00-04:00,CNMD,neutral
271276.0,"CONMED Announces Q2 EPS $0.47 vs $0.46 Est, Sales $193.4M vs $191.48M Est",2016-07-27 17:24:00-04:00,CNMD,neutral
271277.0,"CONMED Raises FY16 Rev. From $760-$770M To $768-$778M , EPS Raised From $1.85-$1.95 To $1.95-$2.05",2016-04-27 17:28:00-04:00,CNMD,neutral
271278.0,"CONMED Corp. Reports Q1 EPS $0.42 vs. Est. $0.41, Rev. $181.2M vs. Est. $180M",2016-04-27 17:26:00-04:00,CNMD,neutral
271279.0,Jeremy Mindich Reports 7.6% Stake In Conmed as of March 7 vs 6.1% as of Feb 19 -13D,2016-03-09 16:34:00-05:00,CNMD,neutral
271280.0,13D Filing Shows Conmed Holder Scopia Capital Mgmt Holds 5.9% As Of Jan 27,2016-01-27 16:22:00-05:00,CNMD,neutral
271281.0,"CONMED Sees FY16 Sales $760M-$770M vs $778M Est., Adj. EPS $1.85-$1.95 vs $1.80 Est.",2016-01-27 16:03:00-05:00,CNMD,neutral
271282.0,"CONMED Reports Q4 Adj. EPS $0.52 vs $0.51 Est., Sales $191M vs $191M Est.",2016-01-27 16:02:00-05:00,CNMD,neutral
271283.0,Conmed Announces Acquisition of SurgiQuest for $265M,2015-11-16 07:01:00-05:00,CNMD,neutral
271284.0,Shares of CONMED Trading Down Nearly 8% in Post-Market Action,2015-10-21 16:14:00-04:00,CNMD,positive
271285.0,UPDATE: CONMED Cuts FY15 Adj. EPS Outlook from $1.82-$1.92 to $1.65-$1.70 vs $1.83 Est.,2015-10-21 16:03:00-04:00,CNMD,negative
271286.0,CONMED Cuts FY15 Outlook,2015-10-21 16:02:00-04:00,CNMD,negative
271287.0,"CONMED Corp. Reports Q3 EPS $0.38 vs. Est. $0.43, Rev. $169.2M vs. Est. $173.69M",2015-10-21 16:02:00-04:00,CNMD,neutral
271288.0,CONMED Corporation Appoints Nathan Folkert as Vice President and General Manager of Orthopedics,2015-09-24 16:09:00-04:00,CNMD,neutral
271289.0,2 Medical Technology Stocks To Weather Market Pullback,2015-08-25 13:49:00-04:00,CNMD,neutral
271290.0,Northland Securities Downgrades Conmed to Market Perform,2015-07-22 07:58:00-04:00,CNMD,positive
271291.0,"Conmed Officer Beyer Buys 5,000 Shares @$53.36/Share -Form 4",2015-05-08 09:47:00-04:00,CNMD,positive
271292.0,Benzinga's Top Initiations,2015-05-04 09:34:00-04:00,CNMD,positive
271293.0,Deutsche Bank Initiates CONMED With Buy,2015-05-04 09:20:00-04:00,CNMD,neutral
271294.0,CONMED Shares Initiated With Buy At Deutsche Bank,2015-05-04 08:05:00-04:00,CNMD,positive
271295.0,"Deutsche Bank Initiates Coverage on Conmed at Buy, Announces $63.00 PT",2015-05-04 07:19:00-04:00,CNMD,neutral
271296.0,"Deutsche Bank Initiates Coverage on Conmed at Buy, Announces $63.00 PT",2015-05-04 07:19:00-04:00,CNMD,neutral
271297.0,"Ladenburg Thalmann Downgrades Conmed to Neutral, Maintains $55.00 PT",2015-04-24 08:19:00-04:00,CNMD,neutral
271298.0,"CONMED Reports Q1 Adj. EPS $0.42 vs $0.43 Est., Sales $177.9M vs $175M Est.; Sees FY Adj. EPS $1.82-$1.92 vs $1.86 Est.,",2015-04-22 16:28:00-04:00,CNMD,neutral
271299.0,KeyBanc Initiates Coverage on Conmed at Sector Weight,2015-03-16 06:06:00-04:00,CNMD,neutral
271300.0,Top 4 Small-Cap Stocks In The Medical Appliances & Equipment Industry With The Highest Dividend Yield,2015-02-10 04:36:00-05:00,CNMD,positive
271301.0,"CONMED Reports Q4 Adj. EPS $0.53 vs $0.54 Est., Sales $195M",2015-01-27 16:02:00-05:00,CNMD,neutral
271302.0,Conmed Sees FY2015 EPS $1.92-2.02 vs $2.02 Est; Sees Sales $740.0M-755.0M vs $746.50M Est,2015-01-14 07:02:00-05:00,CNMD,neutral
271303.0,Conmed Reports Prelim. FY2014 EPS $1.90-1.94 vs $1.93 Est; Sees Sales $739.0M-741.0M vs $741.10M Est,2015-01-14 07:02:00-05:00,CNMD,neutral
271304.0,"CONMED Corporation Announces EVP ANd CFO TO Retire Mar 31, 2015",2014-12-09 08:05:00-05:00,CNMD,neutral
271305.0,CONMED Issues Voluntary Device Correction For PadPro and R2 Multi-function Defibrillation Electrodes,2014-11-26 11:00:00-05:00,CNMD,neutral
271306.0,Curt Hartman Named President And CEO Of CONMED Corporation,2014-11-10 07:09:00-05:00,CNMD,neutral
271307.0,CONMED Offers Open Letter to Holders,2014-09-02 08:01:00-04:00,CNMD,neutral
271308.0,Glass Lewis Announces Support of Voce Capital's Call for Further Change at CONMED,2014-08-28 12:26:00-04:00,CNMD,positive
271309.0,"Filing from CONMED Shows Letter from Chair to Daniel Plants of Voce Capital, Responds to Firm's Offer to Withdraw Nominees",2014-08-26 13:00:00-04:00,CNMD,neutral
271310.0,Conmed Sends Letter to Shareholders Regarding Board of Directors Election,2014-08-18 07:01:00-04:00,CNMD,neutral
271311.0,Pepsi Beats; Positive Phase 3 Breast Cancer Data Creates Potential Buyout Target,2014-07-23 15:46:00-04:00,CNMD,positive
271312.0,Intuitive Surgical Rises On Upbeat Earnings; Xilinx Shares Slip,2014-07-23 14:19:00-04:00,CNMD,positive
271313.0,Markets Mixed; PepsiCo Q2 Earnings Beat Street View,2014-07-23 11:19:00-04:00,CNMD,neutral
271314.0,Morning Market Losers ,2014-07-23 09:52:00-04:00,CNMD,negative
271315.0,Conmed Makes 4 Bearish Announcements,2014-07-23 08:40:00-04:00,CNMD,neutral
271316.0,"CONMED FY Outlook Reduced from $1.90-2.00 to $1.85-1.95 for EPS, from $770-780M to $735-745M for Sales",2014-07-23 07:17:00-04:00,CNMD,neutral
271317.0,"UPDATE: CONMED Says Joseph Corasanti Has Stepped Down as CEO, Hartman Has Been Named as Interim Replacement",2014-07-23 07:16:00-04:00,CNMD,neutral
271318.0,Conmed Says Board Has Concluded Comprehensive Review of Strategic Alternatives; Says Various Strategic Alternatives do Not Adequately Reflect Intrinsic Value of Co; Decides to Terminate Process,2014-07-23 07:15:00-04:00,CNMD,positive
271319.0,CONMED Corporation Reports Q2 EPS of $0.37 vs $0.47 Est; Revenue of $188.20 vs $191.19M Est,2014-07-23 07:11:00-04:00,CNMD,neutral
271320.0,PREVIEW: COMED to Resume Trading at 7:30 AM ET,2014-07-23 07:06:00-04:00,CNMD,neutral
271321.0,CONMED Halted: Pending News,2014-07-23 06:59:00-04:00,CNMD,neutral
271322.0,Stocks Hitting 52-Week Highs ,2014-05-19 10:15:00-04:00,CNMD,neutral
271323.0,CONMED Corporation Reports Q1 EPS of $0.49 vs $0.47 Est; Revenue of $181.90M vs $191.96M Est; Reaffirms Outlook,2014-04-24 07:05:00-04:00,CNMD,neutral
271324.0,"Benzinga's M&A Chatter for Tuesday April 15, 2014",2014-04-15 17:47:00-04:00,CNMD,neutral
271325.0,Conmed Spokesperson Declines Comment on Rumor Co is for Sale,2014-04-15 16:20:00-04:00,CNMD,neutral
271326.0,Reuters Reports Conmed Explores Sale,2014-04-15 15:34:00-04:00,CNMD,neutral
271327.0,"Option Alert: Conmed Aug $45/$50 Call Spread; 1,975 Spread Contract Trade'; Currently $43.36",2014-04-09 10:10:00-04:00,CNMD,positive
271328.0,"Ladenburg Thalmann Downgrades CONMED Corporation to Neutral, Raises PT to $51.76",2014-02-14 09:25:00-05:00,CNMD,neutral
271329.0,CONMED Corporation Reports Q4 EPS of $0.53 vs $0.49 Est; Revenue of $203.40M vs $197.24M Est,2014-02-13 07:05:00-05:00,CNMD,neutral
271330.0,"CONMED Responds to Voce Capital Release: Says Co. is Successfully Executing on Business Strategy, Will Make Recommendation on Directors in Proxy Statement",2014-02-11 13:17:00-05:00,CNMD,positive
271331.0,13D Filing from Coppersmith Capital on Conmed Shows New 5.9% Stake,2014-02-06 17:35:00-05:00,CNMD,neutral
271332.0,CONMED Raises Qtr. Dividend from $0.15 to $0.20/Share,2013-10-28 07:10:00-04:00,CNMD,neutral
271333.0,CONMED Corporation Sees FY2014 EPS $1.90-2.00 vs $2.03 Est; Sees Sales $770.0M-780.0M vs $772.10M Est,2013-10-24 07:15:00-04:00,CNMD,neutral
271334.0,CONMED Corporation Sees Q4 EPS $0.47-0.52 vs $0.54 Est,2013-10-24 07:15:00-04:00,CNMD,neutral
271335.0,"CONMED Corporation Reports Q3 EPS of $0.40, Inline",2013-10-24 07:15:00-04:00,CNMD,neutral
271336.0,Benzinga's Volume Movers,2013-09-05 10:35:00-04:00,CNMD,neutral
271337.0,CONMED Corporation Adds Two New Board Members ,2013-07-30 16:18:00-04:00,CNMD,neutral
271338.0,CONMED Corporation Reports Q2 EPS of $0.43 vs $0.44 Est; Revenue of $193.0M vs $193.55M Est,2013-07-24 07:12:00-04:00,CNMD,neutral
271339.0,CONMED Corporation Sees Q2 EPS $0.41-0.46 vs $0.45 Est; Sees Sales $191.0M-196.0M vs $195.0M Est,2013-04-25 07:20:00-04:00,CNMD,neutral
271340.0,"CONMED Corporation Reports Q1 EPS of $0.45, Inline; Revenue of $187.0M vs $196.95M Est",2013-04-25 07:20:00-04:00,CNMD,neutral
271341.0,"Piper Jaffray Maintains Conmed at Neutral, Raises PT from $31 to $33",2012-10-31 11:13:00-04:00,CNMD,neutral
271342.0,CONMED Says Completed tender Offer for Outstanding Shares of Viking Systems,2012-09-24 09:30:00-04:00,CNMD,positive
271343.0,"Benzinga'a M&A Chatter for Tuesday August 14, 2012",2012-08-14 17:23:00-04:00,CNMD,neutral
271344.0,A Peek Into The Market Before The Trading Starts,2012-08-14 07:19:00-04:00,CNMD,neutral
271345.0,CONMED Corporation to Acquire Viking Systems,2012-08-14 07:04:00-04:00,CNMD,neutral
271346.0,Ladenburg Thalmann Initiates Coverage on Conmed at Buy,2012-07-25 08:23:00-04:00,CNMD,neutral
271347.0,CONMED Corp.: How Much More Can It Squeeze?,2012-06-07 19:52:00-04:00,CNMD,neutral
271348.0,Why Zillow Trumps Facebook in Our Model,2012-03-09 13:07:00-05:00,CNMD,neutral
271349.0,CONMED Corporation Declares Initial Quarterly Cash Dividend of $0.15  ,2012-03-01 07:21:00-05:00,CNMD,neutral
271350.0,Conmed Reports Q4 EPS $0.46 vs $0.40 Est; Revenues $185.6M vs $184.97M Est				 ,2012-02-15 09:06:00-05:00,CNMD,neutral
271351.0,Weekly Homework: Can Bonds Break The Trend? ,2012-01-23 00:06:00-05:00,CNMD,neutral
271352.0,Weekly Homework: When Will Bonds Unravel? (w/ Economic Calendar & Stock Radar),2012-01-16 23:35:00-05:00,CNMD,neutral
271353.0,CONMED Corporation Partners With the Musculoskeletal Transplant Foundation for Sports Medicine; Expects to Be Accretive to 2012 Earnings by 0.15 - $0.18 per Share ,2012-01-03 16:04:00-05:00,CNMD,positive
271354.0,"Piper Jaffray Reiterates Neutral, $31 PT on CONMED ",2011-12-01 10:04:00-05:00,CNMD,neutral
271355.0,"Medtronic Earnings Preview: Analysts Expect Flat EPS, Rising Revenue",2011-11-17 09:43:00-05:00,CNMD,neutral
271356.0,UPDATE: Piper Jaffray Lowers PT on CONMED ,2011-10-28 09:59:00-04:00,CNMD,negative
271357.0,"Piper Jaffray Lowers PT on CONMED to $31, Maintains Neutral ",2011-10-28 07:55:00-04:00,CNMD,negative
271358.0,"Earnings Preview: Intuitive Surgical's EPS, Revenue Expected to Rise",2011-10-14 10:19:00-04:00,CNMD,neutral
271359.0,"Earnings Preview: Stryker's EPS, Revenue Expected to Rise",2011-10-14 10:19:00-04:00,CNMD,neutral
271360.0,CONMED Reports Q2 EPS $0.35 vs $0.35 Est; Revenues $183.2M vs $185.81M Est  ,2011-07-28 08:00:00-04:00,CNMD,neutral
271361.0,"Earnings Preview: Stryker EPS, Revenue Expected to Rise from Previous Quarter",2011-07-19 12:39:00-04:00,CNMD,neutral
271362.0,CONMED Corporation Reports EPS of $0.31 vs. $0.31 Estimate; Revenues $183.5M vs. $181.85M Estimate (CNMD),2011-04-28 08:46:00-04:00,CNMD,neutral
271363.0,CONMED Misses Revenue Estimates (CNMD),2011-02-03 07:27:00-05:00,CNMD,negative
271364.0,Earnings Scorecard: Stryker - Analyst Blog,2011-01-31 15:01:00-05:00,CNMD,neutral
271365.0,Earnings Scorecard: Stryker - Analyst Blog,2011-01-31 14:19:00-05:00,CNMD,neutral
271366.0,Stryker Beats but Concerns Linger - Analyst Blog,2011-01-26 09:31:00-05:00,CNMD,neutral
271367.0,Stryker Beats but Concerns Linger - Analyst Blog,2011-01-26 09:15:00-05:00,CNMD,neutral
271368.0,Earnings Preview: Stryker - Analyst Blog,2011-01-24 12:01:00-05:00,CNMD,neutral
271369.0,Earnings Preview: Stryker - Analyst Blog,2011-01-24 11:30:00-05:00,CNMD,neutral
271370.0,Stryker Rises on Buoyant View - Analyst Blog,2011-01-11 14:01:00-05:00,CNMD,positive
271371.0,Stryker Rises on Buoyant View - Analyst Blog,2011-01-11 13:19:00-05:00,CNMD,positive
271372.0,Zacks #5 Rank Additions for Thursday - Tale of the Tape,2010-12-23 08:33:00-05:00,CNMD,neutral
271373.0,Zacks #5 Rank Additions for Thursday - Tale of the Tape,2010-12-23 08:14:00-05:00,CNMD,neutral
271374.0,Stryker Enhances Return - Analyst Blog,2010-12-09 18:33:00-05:00,CNMD,neutral
271375.0,Stryker Enhances Return - Analyst Blog,2010-12-09 17:56:00-05:00,CNMD,neutral
271376.0,FDA OKs Conmed Tissue Device  - Analyst Blog,2010-12-07 20:15:00-05:00,CNMD,neutral
271377.0,Stryker to Jettison OP-1 for $60M - Analyst Blog,2010-12-07 20:15:00-05:00,CNMD,neutral
271378.0,Stryker to Jettison OP-1 for $60M - Analyst Blog,2010-12-07 18:10:00-05:00,CNMD,neutral
271379.0,FDA OKs Conmed Tissue Device  - Analyst Blog,2010-12-07 16:59:00-05:00,CNMD,neutral
271380.0,Medical Devices Industry Outlook - Dec. 2010 - Zacks Analyst Interviews,2010-12-06 17:30:00-05:00,CNMD,neutral
271381.0,Medical Devices Industry Outlook - Dec. 2010 - Industry Outlook,2010-12-06 17:30:00-05:00,CNMD,neutral
271382.0,Medical Devices Industry Outlook – Dec. 2010 - Industry Outlook,2010-12-06 17:30:00-05:00,CNMD,neutral
271383.0,Medical Devices Industry Outlook – Dec. 2010 - Industry Outlook,2010-12-06 16:57:00-05:00,CNMD,neutral
271384.0,Piper Jaffray Remains Neutral On CONMED Corp.  (CNMD,2010-12-06 07:16:00-05:00,CNMD,neutral
271385.0,Medical Devices Industry Outlook - Dec. 2010 - Zacks Analyst Interviews,2010-12-06 00:00:00-05:00,CNMD,neutral
271386.0,Medical Devices Industry Outlook - Dec. 2010 - Industry Outlook,2010-12-06 00:00:00-05:00,CNMD,neutral
271387.0,Hanger Closes ACP Acquisition - Analyst Blog,2010-12-03 09:30:00-05:00,CNMD,neutral
271388.0,Hanger Closes ACP Acquisition - Analyst Blog,2010-12-03 04:09:00-05:00,CNMD,neutral
271389.0,Conmed 3Q Profit Rockets - Analyst Blog,2010-11-02 11:33:00-04:00,CNMD,positive
271390.0,Earnings Preview: Stryker - Analyst Blog,2010-10-18 14:45:00-04:00,CNMD,neutral
271391.0,The Daily Long and Short Setup,2010-09-13 08:07:00-04:00,CNMD,neutral
271392.0,Medical Devices Industry Outlook - August 2010 - Industry Outlook,2010-08-24 19:15:00-04:00,CNMD,neutral
271393.0,Conmed Lifted to Neutral  - Analyst Blog,2010-08-13 16:22:00-04:00,CNMD,neutral
271394.0,Hanger Remains “Outperform” - Analyst Blog,2010-08-03 13:48:00-04:00,CNMD,neutral
271395.0,"Conmed Tops, Profit Soars - Analyst Blog",2010-07-30 14:36:00-04:00,CNMD,positive
271396.0,CL King Initiates Coverage of Conmed,2010-03-26 09:43:00-04:00,CNMD,neutral
